DF/Net is pleased to announce our selection as one of five preferred providers to the Global Health Clinical Consortium (GHCC). DF/Net provides clinical trial data management software and services for biotech, pharmaceutical, non-profit and academic research organizations worldwide.
The GHCC is a collaboration of clinical operations leaders from 14 Product Development Partners (PDPs) supporting global health research in more than 21 disease areas. These organizations are conducting 132 ongoing and planned trials to develop and test vaccines, microbicides, therapeutics, and diagnostics at 295 clinical research sites worldwide. The PDPs receive funding from the Bill & Melinda Gates Foundation.
DF/Net has worked with several of the PDPs for many years, and looks forward to expanding our presence in global health clinical research, building strong and lasting relationships with GHCC member organizations, and continuing to provide high quality data management services to our collaborators.
“We are honored with our selection as a preferred provider and look forward to collaborating with some of the world’s top research organizations on these important global health challenges,” said Lisa Ondrejcek, DF/Net President and co-founder. “As an emerging company, being selected to work alongside larger, full-service Clinical Research Organizations is a testament to our reputation for excellence in clinical data management and commitment to our clients over the past thirteen years.”
Since 2004, DF/Net has managed more than 140 studies in 18 disease areas across 34 countries, using our flexible hybrid approach to data collection.
DF/Net’s people, products, and services help our global clients realize and recognize the truth in their endeavors.
